123 related articles for article (PubMed ID: 26249805)
1. ALK7 protects against pathological cardiac hypertrophy in mice.
Huang H; Tang Y; Wu G; Mei Y; Liu W; Liu X; Wan N; Liu Y; Huang C
Cardiovasc Res; 2015 Oct; 108(1):50-61. PubMed ID: 26249805
[TBL] [Abstract][Full Text] [Related]
2. Regulator of G protein signaling 3 protects against cardiac hypertrophy in mice.
Liu Y; Huang H; Zhang Y; Zhu XY; Zhang R; Guan LH; Tang Q; Jiang H; Huang C
J Cell Biochem; 2014 May; 115(5):977-86. PubMed ID: 24375609
[TBL] [Abstract][Full Text] [Related]
3. Caspase recruitment domain 6 protects against cardiac hypertrophy in response to pressure overload.
Li L; Chen W; Zhu Y; Wang X; Jiang DS; Huang F; Wang L; Xiang F; Qin W; Wang Q; Zhang R; Zhu X; Li H; Chen X
Hypertension; 2014 Jul; 64(1):94-102. PubMed ID: 24777975
[TBL] [Abstract][Full Text] [Related]
4. Growth/differentiation factor 1 alleviates pressure overload-induced cardiac hypertrophy and dysfunction.
Zhang Y; Zhang XF; Gao L; Liu Y; Jiang DS; Chen K; Yang Q; Fan GC; Zhang XD; Huang C
Biochim Biophys Acta; 2014 Feb; 1842(2):232-44. PubMed ID: 24275554
[TBL] [Abstract][Full Text] [Related]
5. Cardiac-specific mindin overexpression attenuates cardiac hypertrophy via blocking AKT/GSK3β and TGF-β1-Smad signalling.
Yan L; Wei X; Tang QZ; Feng J; Zhang Y; Liu C; Bian ZY; Zhang LF; Chen M; Bai X; Wang AB; Fassett J; Chen Y; He YW; Yang Q; Liu PP; Li H
Cardiovasc Res; 2011 Oct; 92(1):85-94. PubMed ID: 21632881
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin-Converting Enzyme 3 (ACE3) Protects Against Pressure Overload-Induced Cardiac Hypertrophy.
Yu CJ; Tang LL; Liang C; Chen X; Song SY; Ding XQ; Zhang KY; Song BL; Zhao D; Zhu XY; Li HL; Zhang ZR
J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26892527
[TBL] [Abstract][Full Text] [Related]
7. Stem cell antigen 1 protects against cardiac hypertrophy and fibrosis after pressure overload.
Zhou H; Bian ZY; Zong J; Deng W; Yan L; Shen DF; Guo H; Dai J; Yuan Y; Zhang R; Lin YF; Hu X; Li H; Tang QZ
Hypertension; 2012 Sep; 60(3):802-9. PubMed ID: 22851736
[TBL] [Abstract][Full Text] [Related]
8. Partial inhibition of activin receptor-like kinase 4 attenuates pressure overload-induced cardiac fibrosis and improves cardiac function.
Li CY; Chen YH; Wang Q; Hou JW; Wang H; Wang YP; Li YG
J Hypertens; 2016 Sep; 34(9):1766-77. PubMed ID: 27379535
[TBL] [Abstract][Full Text] [Related]
9. Cardioprotective role of growth/differentiation factor 1 in post-infarction left ventricular remodelling and dysfunction.
Bao MW; Zhang XJ; Li L; Cai Z; Liu X; Wan N; Hu G; Wan F; Zhang R; Zhu X; Xia H; Li H
J Pathol; 2015 Jul; 236(3):360-72. PubMed ID: 25726944
[TBL] [Abstract][Full Text] [Related]
10. Caffeic acid phenethyl ester attenuates pathological cardiac hypertrophy by regulation of MEK/ERK signaling pathway in vivo and vitro.
Ren J; Zhang N; Liao H; Chen S; Xu L; Li J; Yang Z; Deng W; Tang Q
Life Sci; 2017 Jul; 181():53-61. PubMed ID: 28449869
[TBL] [Abstract][Full Text] [Related]
11. Baicalein protects against cardiac hypertrophy through blocking MEK-ERK1/2 signaling.
Zong J; Zhang DP; Zhou H; Bian ZY; Deng W; Dai J; Yuan Y; Gan HW; Guo HP; Tang QZ
J Cell Biochem; 2013 May; 114(5):1058-65. PubMed ID: 23225340
[TBL] [Abstract][Full Text] [Related]
12. SH2B1 is critical for the regulation of cardiac remodelling in response to pressure overload.
Wu G; Liu Y; Huang H; Tang Y; Liu W; Mei Y; Wan N; Liu X; Huang C
Cardiovasc Res; 2015 Jul; 107(2):203-15. PubMed ID: 26077624
[TBL] [Abstract][Full Text] [Related]
13. Interferon regulatory factor 7 functions as a novel negative regulator of pathological cardiac hypertrophy.
Jiang DS; Liu Y; Zhou H; Zhang Y; Zhang XD; Zhang XF; Chen K; Gao L; Peng J; Gong H; Chen Y; Yang Q; Liu PP; Fan GC; Zou Y; Li H
Hypertension; 2014 Apr; 63(4):713-22. PubMed ID: 24396025
[TBL] [Abstract][Full Text] [Related]
14. Dual-specificity phosphatase 14 protects the heart from aortic banding-induced cardiac hypertrophy and dysfunction through inactivation of TAK1-P38MAPK/-JNK1/2 signaling pathway.
Li CY; Zhou Q; Yang LC; Chen YH; Hou JW; Guo K; Wang YP; Li YG
Basic Res Cardiol; 2016 Mar; 111(2):19. PubMed ID: 26891723
[TBL] [Abstract][Full Text] [Related]
15. Novel role for caspase-activated DNase in the regulation of pathological cardiac hypertrophy.
Gao L; Huang K; Jiang DS; Liu X; Huang D; Li H; Zhang XD; Huang K
Hypertension; 2015 Apr; 65(4):871-81. PubMed ID: 25646292
[TBL] [Abstract][Full Text] [Related]
16. Targeting Transmembrane BAX Inhibitor Motif Containing 1 Alleviates Pathological Cardiac Hypertrophy.
Deng KQ; Zhao GN; Wang Z; Fang J; Jiang Z; Gong J; Yan FJ; Zhu XY; Zhang P; She ZG; Li H
Circulation; 2018 Apr; 137(14):1486-1504. PubMed ID: 29229612
[TBL] [Abstract][Full Text] [Related]
17. Puerarin attenuates pressure overload-induced cardiac hypertrophy.
Yuan Y; Zong J; Zhou H; Bian ZY; Deng W; Dai J; Gan HW; Yang Z; Li H; Tang QZ
J Cardiol; 2014 Jan; 63(1):73-81. PubMed ID: 23906530
[TBL] [Abstract][Full Text] [Related]
18. Leukocyte immunoglobulin-like receptor B4 protects against cardiac hypertrophy via SHP-2-dependent inhibition of the NF-κB pathway.
Zhou H; Li N; Yuan Y; Jin YG; Wu Q; Yan L; Bian ZY; Deng W; Shen DF; Li H; Tang QZ
J Mol Med (Berl); 2020 May; 98(5):691-705. PubMed ID: 32280997
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction.
Zhong J; Basu R; Guo D; Chow FL; Byrns S; Schuster M; Loibner H; Wang XH; Penninger JM; Kassiri Z; Oudit GY
Circulation; 2010 Aug; 122(7):717-28, 18 p following 728. PubMed ID: 20679547
[TBL] [Abstract][Full Text] [Related]
20. Signal regulatory protein-α protects against cardiac hypertrophy via the disruption of toll-like receptor 4 signaling.
Jiang DS; Zhang XF; Gao L; Zong J; Zhou H; Liu Y; Zhang Y; Bian ZY; Zhu LH; Fan GC; Zhang XD; Li H
Hypertension; 2014 Jan; 63(1):96-104. PubMed ID: 24101669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
